eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Dermal Laboratories Limited

Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR
Telephone: +44 (0)1462 458 866
Fax: +44 (0)1462 420 565
WWW: http://www.dermal.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 20/06/2011
SPC Glutarol 10% w/v Cutaneous Solution


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

GLUTAROL™ 10% w/v CUTANEOUS SOLUTION


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Glutaraldehyde 10.0% w/v.


Go to top of the page
3. PHARMACEUTICAL FORM

Colourless, evaporative cutaneous solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the topical treatment of warts, especially plantar warts.


Go to top of the page
4.2 Posology and method of administration

For adults, children and the elderly:

1. Gently rub the surface of the wart with a piece of pumice stone or manicure emery board, or pare down any hard skin.

2. Using the applicator provided, carefully apply a few drops of the paint to the wart, taking care to localise the application to the affected area. Allow each drop to dry before the next is applied.

3. Repeat twice daily.

4. On subsequent days, repeat steps 1 to 3. It is not necessary to cover the treated wart(s) with an adhesive plaster.


Go to top of the page
4.3 Contraindications

Not to be used in cases of sensitivity to any of the ingredients. Not to be used on the face, anal or perineal region. Not to be used on moles or on any other skin lesion for which it is not indicated.


Go to top of the page
4.4 Special warnings and precautions for use

Keep away from the eyes and mucous membranes. Avoid spreading onto surrounding uninvolved skin. Avoid spillage. Avoid inhaling vapour. Replace cap tightly after use. For external use only.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

No special precautions.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Undesirable effects occur very occasionally and mostly involve mild local skin rashes and irritation. Very rarely, a severe reaction may occur particularly on the hands or when the product is used excessively and allowed to spread onto surrounding normal skin. If mild irritation should occur, apply a reduced amount (taking special care to avoid spreading beyond the wart or verruca) and apply less often. If the irritation is severe, patients should stop treatment immediately and seek medical advice.


Go to top of the page
4.9 Overdose

Accidental oral ingestion should be treated immediately by gastric lavage with 2 to 5% aqueous sodium bicarbonate solution. Fluid and electrolyte balance should be monitored and appropriate supportive measures should be provided. Symptoms include headache, nausea, vomiting, diarrhoea and respiratory depression.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Glutaraldehyde is virucidal and thus inactivates the wart virus. On the skin, it also acts as an anhidrotic, drying the warts and surrounding skin, thus reducing the spread of lesions and simplifying the removal of persistent warts by curettage.

As glutaraldehyde stains the outer layer of the skin brown, treatment can be seen to be carried out. This stain soon disappears after cessation of treatment.


Go to top of the page
5.2 Pharmacokinetic properties

Addition of ethanol to the formulation stabilises the glutaraldehyde against irreversible polymerisation during storage but at the same time diminishes its activity. However, when the aqueous ethanolic solution is applied to the skin, the alcohol rapidly evaporates leaving a concentrated aqueous solution of glutaraldehyde which is highly reactive and attacks the wart before it has time to polymerise. Thus, the ethanolic formulation is stable in storage, as confirmed by stability tests, but is immediately activated when applied to the skin and the alcohol is allowed to evaporate.


Go to top of the page
5.3 Preclinical safety data

No relevant information additional to that contained elsewhere in the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

IMS; Purified Water.


Go to top of the page
6.2 Incompatibilities

None known.


Go to top of the page
6.3 Shelf life

36 months.


Go to top of the page
6.4 Special precautions for storage

Flammable. Keep away from flames. Keep upright. Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

10 ml amber glass bottle with plastic screw cap, incorporating a specially designed spatula for ease of application.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not applicable.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Dermal Laboratories

Tatmore Place, Gosmore

Hitchin, Herts SG4 7QR, UK.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

00173/0022.


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

15 September 2005.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

June 2011.



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/482/SPC/


Active Ingredients/Generics

 
   glutaraldehyde